JPRN-UMIN000010324已完成未知
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancer - CBDCA/ weekly nab-PTX for elderly NSCLC patients
orth Japan Lung Cancer Study Group0 个研究点目标入组 35 人开始时间: 2013年3月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Previous treatment with paclitaxel as adjuvant chemotherapy 2) Active double cancer 3) Symptomatic brain metastasis 4) Pleural and peritoneal effusion likely to require surgical intervention, or pericardial effusion 5) Grade 2 or higher peripheral neuropathy 6) Radiographically confirmed interstitial pneumonitis or pulmonary fibrosis 7) Severe concurrent disease (Ischemic heart disease requiring treatment, arrhythmia, cardiac infarction within 6 months before enrollment, hepatic failure, hemorrhagic peptic ulcer, poorly controlled diabetes) 8) History of Severe drug allergies. 9) Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males that are currently attempting to produce a pregnancy. 10) Physician concludes that the patient's participation in this trial is inappropriate.
研究者
相似试验
已完成
2 期
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancer using MNASquamous cell lung cancerJPRN-UMIN000012051OSAKA-LCSG30
已完成
不适用
A Phase II Study of biweekly Carboplatin, nab-paclitaxel, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung CancerJPRN-UMIN000023802Hirosaki University28
已完成
2 期
Phase 2 study of carboplatin and weekly nab-paclitaxel for elderly squamous cell lung cancersquamous cell lung cancerJPRN-UMIN000012025Osaka City General Hospital35
已完成
不适用
A phase II study of concurrent weekly carboplatin and paclitaxel combined with definitive radiotherapy for advanced-stage cervical cancer.terine cervical cancerJPRN-UMIN000017232Osaka University Hospital80
招募中
1 期
Phase I trial of biweekly Carboplatin plus nab-Paclitaxel with concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung canceron-small cell lung cancerJPRN-UMIN000010480Aomori Prefectural Central Hospital18
